Articles tagged "Outcome"

2016 American Transplant Congress
Utility in Treating Renal Failure in End-Stage Liver Disease with Simultaneous Liver-Kidney Transplantation.
X. Cheng,¹ M. Stedman,¹ W. Kim,² J. Tan.¹
¹Division of Nephrology, Stanford University, Palo Alto, CA; ²Division of Gastroenterology and Hepatology, Stanford University, Palo Alto, CA.
The number of simultaneous liver-kidney transplants (SLKT) for end-stage liver disease (ESLD) with renal failure is rising. The overall utility of kidneys used in this…
2016 American Transplant Congress
Factors and Outcomes Associated with Daptomycin Non-Susceptible Enterococcal Infections in Solid Organ Transplant Recipients.
K. Younan,¹ R. Lee,¹ T. McCarty,¹ D. Kunz,² J. Locke,³ B. Camins,¹ P. Pappas,¹ J. Baddley,¹ A. Nellore.¹
¹Medicine, University of Alabama at Birmingham, Birmingham, AL; ²Pharmacy, University of Alabama at Birmingham, Birmingham, AL; ³Surgery, University of Alabama at Birmingham, Birmingham, AL.
Background: Daptomycin non-susceptible enterococcal (DNSE) infections are associated with poor outcomes. Information regarding factors and outcomes of DNSE in solid organ transplant (SOT) recipients (SOTR)…
2016 American Transplant Congress
Kidney Retransplantation Is Associated with Higher Mortality Risk Among HIV+ vs. HIV- Recipients.
B. Shelton,¹ S. Mehta,¹ D. Sawinski,² R. Reed,¹ P. MacLennan,¹ S. Gustafson,³ C. Durand,⁴ D. Segev,⁴ J. Locke.¹
¹School of Medicine, University of Alabama at Birmingham, Birmingham, AL; ²School of Medicine, University of Pennsylvania, Philadelphia, PA; ³Scientific Registry of Transplant Recipients, Minneapolis, MN; ⁴School of Medicine, Johns Hopkins University, Baltimore, MD.
Background: Excellent outcomes have been demonstrated in HIV+ kidney transplant (KT) recipients, yet no study has explored outcomes among HIV+ reKT recipients.Methods: 4,683 adult reKT…
2016 American Transplant Congress
Is Prolonged Cold Ischemia a Contraindication to Using Kidneys from Acute Kidney Injury Donors?
M. Khan,¹ A. Carrier,¹ H. El-Hennawy,¹ A. Farney,¹ J. Rogers,¹ G. Orlando,¹ A. Reeves-Daniel,² A. Palanisamy,² M. Gautreaux,³ S. Iskandar,³ W. Doares,⁴ S. Kaczmorski,⁴ R. Stratta.¹
¹Surgery, Wake Forest, Winston-Salem, NC; ²Internal Medicine, Wake Forest, Winston-Salem, NC; ³Pathology, Wake Forest, Winston-Salem, NC; ⁴Pharmacy, Wake Forest, Winston-Salem, NC.
Elevated deceased donor (DD) serum creatinine (SCr) levels and prolonged cold ischemia time (CIT) are major independent reasons for kidney discard following organ recovery. Many…
2016 American Transplant Congress
Validation of SUITO Index and C-Peptide/Glucose Creatinine Ratio as Convenient Tools for the Evaluation of the Short and Long-Term Islet Allograft Function.
J. Gołębiewska,¹ J. Solomina,² S. Matosz,² C. Thomas,³ L. Schenck,² K. Golab,² W. Chon,³ S. Ramachandran,² M. Tibudan,² A. Dębska-ŚLizień,¹ B. Rutkowski,¹ P. Witkowski.²
¹Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdańsk, Gdańsk, Poland; ²Department of Surgery, University of Chicago, Chicago, IL; ³Department of Medicine, University of Chicago, Chicago, IL.
Background: Mixed Meal Tolerance Test (MMTT) together with the beta-score are standard tools to evaluate beta-cell function after islet transplantation but utilization of the test…
2016 American Transplant Congress
Long Term Outcome of Kidney Transplant Recipients Treated with Everolimus: Final 5-Years Results from the Certic Observational Study.
L. Furian,¹ L. Di Maria,² G. Cappelli,³ M. Carmellini,⁴ G. Spagnoletti,⁵ G. Piredda,⁶ P. Todeschini,⁷ S. Chiaramonte,⁸ G. Tisone.⁹
¹AOU di Padova, Padova, Italy; ²AOU Careggi, Firenze, Italy; ³AOUP di Modena, Modena, Italy; ⁴AOU Senese, Siena, Italy; ⁵PU A.Gemelli, Roma, Italy; ⁶AO G.Brotzu, Cagliari, Italy; ⁷AOP S.Orsola-Malpighi, Bologna, Italy; ⁸PO S.Bortolo, Vicenza, Italy; ⁹Fondazione PU Tor Vergata, Roma, Italy.
Everolimus is associated with long-term benefits, such as preserving renal function and reducing the incidence of infections, malignancies and major cardiovascular events (MACE). The Certic…
2016 American Transplant Congress
Culture Specific Interventions to Increase Organ Donation Advocacy in a Hispanic Serving Institution.
Y. Tasnif,¹ S. Ghaddar,² S. Saladin,³ A. Alaniz.¹
¹Cooperative Pharmacy Program, University of Texas - Rio Grande Valley, Edinburg, TX; ²South Texas Border Health Disparities Center, University of Texas - Rio Grande Valley, Edinburg, TX; ³School of Rehabilitation Services and Counseling, University of Texas - Rio Grande Valley, Edinburg, TX.
Organ donation rates among Hispanics are lower relative to non-Hispanic whites. The purpose of this study is to assess whether participation in a culture-specific educational…
2016 American Transplant Congress
Pediatric En Bloc Kidney Transplants Reduce DGF and Are Misrepresented by the KDPI.
M. Khan,¹ H. El-Hennawy,¹ A. Farney,¹ J. Rogers,¹ G. Orlando,¹ A. Reeves-Daniel,² A. Palanisamy,² M. Gautreaux,³ S. Iskandar,³ W. Doares,⁴ S. Kaczmorski,⁴ R. Stratta.¹
¹Surgery, Wake Forest, Winston-Salem, NC; ²Internal Medicine, Wake Forest, Winston-Salem, NC; ³Pathology, Wake Forest, Winston-Salem, NC; ⁴Pharmacy, Wake Forest, Winston-Salem, NC.
Controversy exists regarding optimal use of kidneys from small pediatric donors (SPDs). The study purpose was to compare outcomes between single and dual en bloc…
2016 American Transplant Congress
Hospitalizations, Survival, and Complications: 1-Year Outcomes for Elderly Lung Transplant Recipients.
N. Casciello, A. Fuentes, J. Krisl, N. Sinha, T. Kaleekal.
Houston Methodist Hospital, Houston, TX.
Purpose: In 2014, The International Society for Heart and Lung Transplantation published consensus guidelines listing age greater than 65 years as a relative contraindication to…
2016 American Transplant Congress
Kidney Transplant Outcomes in Patients with CPRA Values >98% After Implementation of the New OPTN/UNOS Kidney Allocation System (KAS): A Single Center Study Update.
N. Kaur,¹ S. Goral,¹ J. Kearns,² P. Abt,³ A. Naji,³ P. Porrett,³ M. Levine,³ M. Kamoun.²
¹Renal, Electrolyte and Hypertension Division, University of Pennsylvania Medical Center, Philadelphia; ²Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia; ³Surgery, University of Pennsylvania Medical Center, Philadelphia.
Background: Sensitized patients have had prolonged waiting times and greater incidence of death while on the waiting list. On December 4, 2014, UNOS/OPTN activated a…